Results of a study presented at EAN 2020 demonstrate that it is feasible to assign multiple sclerosis (MS) patients to 5 groups based on homogeneous disease characteristics.
Results of a study presented at EAN 2020 demonstrate that it is feasible to assign multiple sclerosis (MS) patients to 5 groups based on homogeneous disease characteristics.